Fenbo Holdings Ltd. — FY2023 Form 20-F
Reporting period: Fiscal year ended December 31, 2023, with comparison to FY2022. This is an annual filing; it does not provide standalone 2023 fourth-quarter results. Financial amounts below are in Hong Kong dollars (HK$) unless otherwise stated. The company reports under U.S. GAAP.
Business context and financial performance
Fenbo manufactures personal-care electrical appliances, principally hair-styling products, through subsidiaries in Hong Kong and Shenzhen. It operates primarily as an OEM for Spectrum Brands’ Remington brand. Spectrum Brands was its sole customer and accounted for approximately 100% of revenue in 2023, 2022 and 2021. The company completed its Nasdaq IPO in December 2023.
| Metric | FY2023 | FY2022 | Change / context |
|---|---|---|---|
| Revenue | HK$119.1m | HK$119.7m | Down 0.5% |
| Gross profit / margin | HK$22.1m / 18.6% | HK$18.8m / 15.7% | Margin improved 2.9 percentage points |
| Operating income (loss) | (HK$0.4m) | (HK$2.5m) | Operating loss narrowed |
| Net income (loss) | (HK$1.5m) | HK$8.7m | Turned to a loss; FY2022 included a substantial property-disposal gain |
| Net cash from operating activities | HK$9.7m | HK$5.7m | Cash generation increased |
| Net cash used in investing activities | HK$0.3m | HK$0.6m | Mainly property and equipment purchases |
| Net cash from financing activities | HK$23.3m | HK$5.0m | FY2023 chiefly reflected IPO share proceeds, partly offset by related-party advances |
FY2023 revenue was nearly flat, but product mix shifted: curling wands and irons fell 14.5%, while flat irons and straighteners rose 5.3%. Revenue from South America fell to zero; North American revenue increased 7.3% and European revenue decreased 1.9%.
Liquidity, debt and capital
- Year-end cash was HK$46.3m, compared with HK$13.9m a year earlier. Current assets were HK$97.9m and current liabilities HK$43.0m, giving working capital of HK$54.9m.
- Current liabilities included an HK$11.0m revolving bank loan, HK$18.5m accounts payable, HK$7.0m other payables and accrued liabilities, and HK$4.1m current lease liabilities. Total liabilities were HK$43.2m; total lease liabilities were HK$4.3m.
- The bank facility is with Bank of China (Hong Kong), is rolled over every six months, bears interest at 2.25 percentage points below Hong Kong prime, and is supported by a personal guarantee from the controlling shareholder. The filing reports an average bank-loan interest rate of 3.6% for 2023.
- Accounts receivable were HK$31.5m, approximately 30.6% of total assets, and the company recorded no receivable impairment. The customer concentration makes collection and payment timing material liquidity considerations.
- The December 2023 IPO sold 1.0m shares at US$5.00 each for US$5.0m gross proceeds. The cash-flow statement reports HK$26.0m of share proceeds, net of issuance costs. Year-end shares outstanding were 11.0m; the underwriters later purchased 62,500 additional shares in January 2024.
Material changes, outlook and unusual items
- Gross margin recovered from 15.7% in 2022 to 18.6% in 2023. Management attributed the improvement to more stable raw-material supply and prices, lower average unit costs, and fading COVID-related disruption. Management said it believes margins could improve further in 2024 through product-mix and quality optimization and, subject to capital constraints, higher raw-material inventory. No formal revenue or earnings guidance is provided.
- FY2022 net income included a HK$12.5m gain on selling the Hong Kong office to Executive Director and controlling shareholder Li Kin Shing for HK$13.88m. Fenbo subsequently leased the office from him for HK$50,000 per month. The disposal gain largely explains why FY2022 reported profit did not recur in 2023.
- The company reported a HK$1.5m FY2023 net loss despite improved gross profit: general and administrative expenses rose 6.7% to HK$20.5m, and interest expense increased to HK$1.7m. The filing’s narrative contains an apparent inconsistency about whether general and administrative expenses decreased; the comparative expense table shows they increased by HK$1.3m.
- Fenbo relies on order-by-order purchases from its sole customer and has no long-term sales agreement. Management describes expansion of production capacity, R&D, new markets and potential own-brand sales as strategies, but provides no quantified targets or timeline.
- Key risks include customer concentration and bargaining power, receivable collection, raw-material and labor costs, delivery and supply-chain disruption, foreign-exchange exposure without hedging, and regulatory, political and cash-transfer uncertainty related to Hong Kong and mainland China. The company states it had obtained necessary operating licenses and had not received a PRC regulatory objection to its listing as of the report date.
- The company reported no material litigation, no off-balance-sheet arrangements, and no material cybersecurity incident in 2023. It reported effective disclosure controls and no material weakness in internal control over financial reporting; the auditor did not audit or opine on internal-control effectiveness. The financial-statement audit opinion was unqualified.
- No dividends were declared or paid for FY2023, and the company says it does not expect cash dividends in the foreseeable future. PRC statutory reserves and other restrictions limit distributions from the PRC subsidiary.
Important facts for investors to verify
- Whether Spectrum Brands continues placing orders, on what terms, and whether Fenbo can diversify its customer base.
- Receivable aging, subsequent collections and the customer’s share of receivables; also the working-capital effect of customer credit terms and supplier payment terms.
- How much of operating cash flow reflects sustainable trading performance versus changes in payables, inventories and other working-capital items.
- The status, renewal and terms of the HK$11.0m revolving loan, related-party guarantees, and the Shenzhen factory lease, which was due to expire in July 2024.
- The use and availability of IPO proceeds, planned capital spending and R&D investment, and progress toward expansion or own-brand sales.
- The related-party office sale, ongoing lease and other related-party balances and transactions, including appropriate governance and market-term support.
- Any subsequent regulatory, audit-inspection, cash-transfer or listing developments affecting the company’s Hong Kong and mainland China operations.